QUADRANT CAPITAL GROUP LLC - CORCEPT THERAPEUTICS INC ownership

CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 227 filers reported holding CORCEPT THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.47 and the average weighting 0.1%.

Quarter-by-quarter ownership
QUADRANT CAPITAL GROUP LLC ownership history of CORCEPT THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$45,200
+54.8%
1,659
+26.4%
0.01%
+66.7%
Q2 2023$29,192
+11.5%
1,312
+8.5%
0.00%0.0%
Q1 2023$26,187
-10.3%
1,209
-15.9%
0.00%0.0%
Q4 2022$29,206
-27.0%
1,438
-8.5%
0.00%
-40.0%
Q3 2022$40,000
+700.0%
1,571
+714.0%
0.01%
+400.0%
Q2 2022$5,000
-16.7%
193
-27.7%
0.00%0.0%
Q1 2022$6,000
+50.0%
267
+38.3%
0.00%
Q4 2021$4,000
-33.3%
193
-38.7%
0.00%
-100.0%
Q3 2021$6,000
+50.0%
315
+59.1%
0.00%0.0%
Q2 2021$4,000
-20.0%
198
-10.4%
0.00%0.0%
Q1 2021$5,0000.0%221
+14.5%
0.00%0.0%
Q4 2020$5,000
+66.7%
1930.0%0.00%0.0%
Q3 2020$3,0000.0%1930.0%0.00%0.0%
Q2 2020$3,000
-88.5%
193
-91.0%
0.00%
-75.0%
Q1 2020$26,000
+4.0%
2,139
+2.8%
0.00%
+33.3%
Q4 2019$25,000
-13.8%
2,0800.0%0.00%
-25.0%
Q3 2019$29,000
+26.1%
2,0800.0%0.00%0.0%
Q2 2019$23,000
+2200.0%
2,080
+2160.9%
0.00%
Q1 2019$1,0000.0%92
-37.4%
0.00%
Q4 2018$1,0000.0%147
+59.8%
0.00%
Q3 2018$1,0000.0%920.0%0.00%
Q2 2018$1,000
-66.7%
92
-61.2%
0.00%
-100.0%
Q1 2018$3,0000.0%237
+23.4%
0.00%0.0%
Q4 2017$3,0000.0%1920.0%0.00%0.0%
Q3 2017$3,000
+50.0%
1920.0%0.00%0.0%
Q2 2017$2,0000.0%1920.0%0.00%0.0%
Q1 2017$2,0001920.00%
Other shareholders
CORCEPT THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
INGALLS & SNYDER LLC 8,609,429$55,961,0003.12%
INVESTOR AB 1,835,974$11,934,0000.86%
GLOBEFLEX CAPITAL L P 244,183$1,587,0000.40%
Campbell & CO Investment Adviser LLC 21,446$139,0000.37%
Birchview Capital, LP 80,000$520,0000.30%
FEDERATED HERMES, INC. 13,879,968$90,220,0000.26%
MENTA CAPITAL LLC 388,582$2,526,0000.24%
Sitrin Capital Management LLC 40,000$260,0000.20%
ESSEX INVESTMENT MANAGEMENT CO LLC 172,389$1,121,0000.18%
GSA CAPITAL PARTNERS LLP 384,976$2,502,0000.13%
View complete list of CORCEPT THERAPEUTICS INC shareholders